Description: This research report educates the actuarial community about the various shades of the flood risk as well as the state of the art in quantitative flood risk modeling.

Description: The SOA, with SCOR as the researcher, completed an experience study of post-level term (PLT) lapse and mortality. In the first part of this session, the presenters will cover the key findings of the traditional analysis regarding the shock lapse, the PLT lapse and mortality experience. The remainder of the session will focus on the results of the predictive modeling, which will provide further insights into policyholder behavior in the post-level term period.

Description: This presentation develops an integrated approach that addresses simultaneously guaranteed annuity option (GAO)’s pricing and capital requirement calculation.

Description: In this webcast, presenters will outline the key content in ERM ASOPs 46, 47 and 55 and explore the impact each ASOP has on practitioners working in these fields. We will also describe the revision work currently under way in the ERM Committee of the Actuarial Standards Board.

Description: 2021 ImpACT Conference -Insurance ALM Survey - Early Results and Best Practices Recording

Description: This presentation explores the applicability of multiple population versions of the Lee-Carter model in the modelling of mortality by cause of death and socio-economic stratification.

Description: This report provides actuaries and other finance professionals with an example of running the Medicaid Unwinding model with results at the national level on projected changes in both acuity and enrollment for Medicaid and Children’s Health Insurance Program.

Description: Employers, health plans, stop-loss insurers and reinsurers are all affected by the high cost of treating cancer. In recent years, cutting-edge pharmaceuticals, bone marrow transplants and CAR-T cell therapies have driven very high cost trends for cancer, with more emerging therapies on the horizon. In this session, we will review these new treatments, showcase models that aid in understanding the range of likely financial effects of the current, expanded, and likely-to-be approved indications for cell therapies that will treat certain patients affected by lymphoma, leukemia, and multiple myeloma. This session will explain important considerations for modeling Medicare, Medicaid versus commercial populations, key risk concerns caused by the size of enrollee pools, and important differences between the various therapies that affect modeling. We will also discuss averted cost, health outcomes, pricing levels, and risks caused by provider billing practices.

Description: This presentation is a panel discussion, session number 34PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. A fundamental step in stochastic asset/liability modeling is to choose an appropriate underlying economic scenario generator. In this session, panelists discuss various scenario generation techniques and theories, assumptions underlying interest and equity scenario generators, and choosing suitable economic scenario generators for different applications, the two most common being pricing models [for assets and liabilities], and risk analysis models, used for asset/liability management, investment strategy, regulatory solvency, and capital adequacy. Discussion from participants is included.